Design
Editorial
Authors
Loading...
The author argues that clinical pathways should be rigorously tested in robust trials, similar to drugs and devices.
Key points are not available for this paper at this time.
Daniel I. Sessler (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: